ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/06/2023
Back to search
Official data from USPTO
LOARGYS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
12/06/2023
Trademark type
Word
Nice classes
5
Filing date
09/23/2019
Registration date
04/18/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/18/2023
Last transaction
04/18/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/07/2023
First use in commerce
03/07/2023
Drawing code
4
Owner type
64
Owner location
STOCKHOLM, SE
Examiner
SAITO, KIM
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMMEDICA PHARMA AB
Aeglea BioTherapeutics, Inc.
Representatives
Christopher M. Kindel PIRKEY BARBER PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes
Publications
History of USPTO decisions and trademark events.
43 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/18/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/18/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/10/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/10/2023
IUAF
USE AMENDMENT FILED
03/08/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/29/2022
EX5G
SOU EXTENSION 5 GRANTED
12/28/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/28/2022
EXT5
SOU EXTENSION 5 FILED
12/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/03/2022
EX4G
SOU EXTENSION 4 GRANTED
04/29/2022
EXT4
SOU EXTENSION 4 FILED
04/29/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/29/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2021
EX3G
SOU EXTENSION 3 GRANTED
12/08/2021
EXT3
SOU EXTENSION 3 FILED
12/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/10/2021
EX2G
SOU EXTENSION 2 GRANTED
06/08/2021
EXT2
SOU EXTENSION 2 FILED
06/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2020
EX1G
SOU EXTENSION 1 GRANTED
12/03/2020
EXT1
SOU EXTENSION 1 FILED
12/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2020
PUBO
PUBLISHED FOR OPPOSITION
04/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/23/2019
GNRT
NON-FINAL ACTION E-MAILED
12/23/2019
CNRT
NON-FINAL ACTION WRITTEN
12/23/2019
DOCK
ASSIGNED TO EXAMINER
12/23/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2019
NWAP
NEW APPLICATION ENTERED
09/26/2019
Continuous trademark protection
Get notified about every new filing that threatens LOARGYS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.